NeuroSense Therapeutics L...

1.11
0.04 (3.74%)
At close: Feb 28, 2025, 3:57 PM
1.11
-0.23%
After-hours: Feb 28, 2025, 03:58 PM EST

NeuroSense Therapeutics Ltd. Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19
Cash & Equivalents 2.64M 3.54M 11.06M 699K 895K
Short-Term Investments n/a 3.55M n/a n/a n/a
Long-Term Investments 22K 23K n/a 37K 35K
Other Long-Term Assets n/a n/a n/a n/a n/a
Receivables 166K 131K 178K 30K 18K
Inventory n/a -3.68M -178K -67 -18
Other Current Assets 110K 160K 171K n/a n/a
Total Current Assets 2.92M 7.38M 11.41M 729K 913K
Property-Plant & Equipment 238K 306K 19K 13K 7K
Goodwill & Intangibles n/a n/a n/a n/a n/a
Total Long-Term Assets 260K 329K 19K 50K 42K
Total Assets 3.18M 7.71M 11.43M 779K 955K
Account Payables 1.46M 498K 39K 55K 23K
Deferred Revenue n/a n/a n/a n/a n/a
Short-Term Debt 69K 64K n/a n/a n/a
Other Current Liabilities 1.93M 1.16M 558K 65K 14K
Total Current Liabilities 3.46M 1.73M 597K 120K 37K
Long-Term Debt 73K 294K n/a n/a n/a
Other Long-Term Liabilities 1.52M 71K n/a n/a n/a
Total Long-Term Liabilities 1.59M 365K 1.83M n/a n/a
Total Liabilities 5.05M 2.09M 2.42M 120K 37K
Total Debt 142K 211K 1.83M n/a n/a
Common Stock n/a n/a n/a 1K 1K
Retained Earnings -32.07M -20.79M -8.45M -4.41M -1.58M
Comprehensive Income n/a 26.41M 17.45M 5.06M 2.49M
Shareholders Equity -1.87M 5.62M 9.01M 659K 918K
Total Investments 22K 3.55M n/a 37K 35K